{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T09:26:20Z","timestamp":1776763580984,"version":"3.51.2"},"reference-count":95,"publisher":"Public Library of Science (PLoS)","issue":"8","license":[{"start":{"date-parts":[[2024,8,29]],"date-time":"2024-08-29T00:00:00Z","timestamp":1724889600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"three-year action plan for strengthening the construction of the public health system in Shanghai","award":["GWVI-11.2-YQ44"],"award-info":[{"award-number":["GWVI-11.2-YQ44"]}]}],"content-domain":{"domain":["www.plosntds.org"],"crossmark-restriction":false},"short-container-title":["PLoS Negl Trop Dis"],"abstract":"<jats:p>Severe fever with thrombocytopenia syndrome (SFTS) is a newly identified tick-borne viral hemorrhagic fever caused by Dabie Banda virus (DBV). The virus was first discovered in eastern China in 2009 and is now considered an infectious disease with a mortality rate ranging from 6.3% to 30%. The best strategy for controlling SFTS is to develop effective vaccines. However, no approved vaccines are currently available to prevent this disease, despite the number of extensive and in-depth studies conducted on DBV in the past few years. This review focuses on the structure of DBV and the induced host immune responses which are the fundamental factors in vaccine development, and thoroughly summarizes the current research progress on DBV vaccines. The developing DBV vaccines include protein subunit vaccines, live attenuated vaccines, recombinant virus vector vaccines, and DNA vaccines. At present, almost all candidate vaccines for DBV are in the laboratory development or preclinical stages. There remain challenges in successfully developing clinically approved DBV vaccines.<\/jats:p>","DOI":"10.1371\/journal.pntd.0012411","type":"journal-article","created":{"date-parts":[[2024,8,29]],"date-time":"2024-08-29T17:28:01Z","timestamp":1724952481000},"page":"e0012411","update-policy":"https:\/\/doi.org\/10.1371\/journal.pntd.corrections_policy","source":"Crossref","is-referenced-by-count":12,"title":["Recent research advances in the development of Dabie Banda virus vaccines"],"prefix":"10.1371","volume":"18","author":[{"given":"Chenyang","family":"Yu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuxiang","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yixin","family":"Dai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bingan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhongtian","family":"Qi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9654-1260","authenticated-orcid":true,"given":"Xijing","family":"Qian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2024,8,29]]},"reference":[{"issue":"5","key":"pntd.0012411.ref001","doi-asserted-by":"crossref","first-page":"2864","DOI":"10.1128\/JVI.06192-11","article-title":"The ecology, genetic diversity, and phylogeny of Huaiyangshan virus in China","volume":"86","author":"YZ Zhang","year":"2012","journal-title":"J Virol"},{"issue":"11","key":"pntd.0012411.ref002","doi-asserted-by":"crossref","first-page":"e1002369","DOI":"10.1371\/journal.ppat.1002369","article-title":"Metagenomic analysis of fever, thrombocytopenia and leukopenia syndrome (FTLS) in Henan Province, China: discovery of a new bunyavirus.","volume":"7","author":"B Xu","year":"2011","journal-title":"PLoS Pathog."},{"issue":"3","key":"pntd.0012411.ref003","first-page":"209","article-title":"Hemorrhagic fever caused by a novel tick-borne Bunyavirus in Huaiyangshan, China.","volume":"32","author":"YZ Zhang","year":"2011","journal-title":"Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi."},{"issue":"12","key":"pntd.0012411.ref004","doi-asserted-by":"crossref","first-page":"e0005264","DOI":"10.1371\/journal.pntd.0005264","article-title":"Severe Fever with Thrombocytopenia Syndrome in South Korea, 2013\u20132015.","volume":"10","author":"SJ Choi","year":"2016","journal-title":"PLoS Negl Trop Dis."},{"issue":"16","key":"pntd.0012411.ref005","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1056\/NEJMoa1010095","article-title":"Fever with thrombocytopenia associated with a novel bunyavirus in China","volume":"364","author":"XJ Yu","year":"2011","journal-title":"N Engl J Med"},{"issue":"7","key":"pntd.0012411.ref006","doi-asserted-by":"crossref","first-page":"637","DOI":"10.3851\/IMP3036","article-title":"Successful treatment of rapidly progressing severe fever with thrombocytopenia syndrome with neurological complications using intravenous immunoglobulin and corticosteroid.","volume":"21","author":"UJ Kim","year":"2016","journal-title":"Antivir Ther"},{"issue":"5","key":"pntd.0012411.ref007","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1093\/infdis\/jis748","article-title":"Human-to-human transmission of severe fever with thrombocytopenia syndrome bunyavirus through contact with infectious blood","volume":"207","author":"X Tang","year":"2013","journal-title":"J Infect Dis"},{"issue":"2","key":"pntd.0012411.ref008","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1089\/vbz.2011.0758","article-title":"Person-to-person transmission of severe fever with thrombocytopenia syndrome virus.","volume":"12","author":"Y Liu","year":"2012","journal-title":"Vector Borne Zoonotic Dis (Larchmont, NY)."},{"issue":"12","key":"pntd.0012411.ref009","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1093\/cid\/cir732","article-title":"A family cluster of infections by a newly recognized bunyavirus in eastern China, 2007: further evidence of person-to-person transmission","volume":"53","author":"CJ Bao","year":"2011","journal-title":"Clin Infect Dis"},{"issue":"2","key":"pntd.0012411.ref010","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1093\/cid\/cir776","article-title":"Person-to-person transmission of severe fever with thrombocytopenia syndrome bunyavirus through blood contact","volume":"54","author":"Z Gai","year":"2012","journal-title":"Clin Infect Dis"},{"key":"pntd.0012411.ref011","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.biologicals.2017.01.005","article-title":"Identification of a candidate standard strain of severe fever with thrombocytopenia syndrome virus for vaccine quality control in China using a cross-neutralization assay","volume":"46","author":"Z Jia","year":"2017","journal-title":"Biologicals"},{"issue":"4","key":"pntd.0012411.ref012","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1093\/cid\/cir804","article-title":"Hemorrhagic fever caused by a novel Bunyavirus in China: pathogenesis and correlates of fatal outcome","volume":"54","author":"YZ Zhang","year":"2012","journal-title":"Clin Infect Dis"},{"issue":"10","key":"pntd.0012411.ref013","doi-asserted-by":"crossref","first-page":"e0165207","DOI":"10.1371\/journal.pone.0165207","article-title":"Epidemiological and Clinical Features of Severe Fever with Thrombocytopenia Syndrome in Japan, 2013\u20132014.","volume":"11","author":"H Kato","year":"2016","journal-title":"PLoS ONE."},{"issue":"11","key":"pntd.0012411.ref014","doi-asserted-by":"crossref","first-page":"e111736","DOI":"10.1371\/journal.pone.0111736","article-title":"Age is a critical risk factor for severe fever with thrombocytopenia syndrome.","volume":"9","author":"S Ding","year":"2014","journal-title":"PLoS ONE."},{"issue":"1","key":"pntd.0012411.ref015","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s12250-016-3931-1","article-title":"Current status of severe fever with thrombocytopenia syndrome in China.","volume":"32","author":"J Zhan","year":"2017","journal-title":"Virol Sin"},{"issue":"2","key":"pntd.0012411.ref016","article-title":"Genetic and pathogenic diversity of severe fever with thrombocytopenia syndrome virus (SFTSV) in South Korea.","volume":"5","author":"SM Yun","year":"2020","journal-title":"JCI Insight."},{"issue":"4","key":"pntd.0012411.ref017","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s10238-013-0259-0","article-title":"Detection and evaluation of immunofunction of patients with severe fever with thrombocytopenia syndrome.","volume":"14","author":"L Sun","year":"2014","journal-title":"Clin Exp Med"},{"issue":"100","key":"pntd.0012411.ref018","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.coviro.2014.01.011","article-title":"Emerging phleboviruses.","volume":"5","author":"RM Elliott","year":"2014","journal-title":"Curr Opin Virol"},{"issue":"2","key":"pntd.0012411.ref019","doi-asserted-by":"crossref","first-page":"e1007375","DOI":"10.1371\/journal.ppat.1007375","article-title":"An anti-Gn glycoprotein antibody from a convalescent patient potently inhibits the infection of severe fever with thrombocytopenia syndrome virus.","volume":"15","author":"KH Kim","year":"2019","journal-title":"PLoS Pathog."},{"issue":"1\u20134","key":"pntd.0012411.ref020","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/BF01309641","article-title":"The synergistic neutralization of Rift Valley fever virus by monoclonal antibodies to the envelope glycoproteins","volume":"125","author":"TG Besselaar","year":"1992","journal-title":"Arch Virol"},{"issue":"9","key":"pntd.0012411.ref021","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1128\/CVI.00222-13","article-title":"Human antibody neutralizes severe Fever with thrombocytopenia syndrome virus, an emerging hemorrhagic Fever virus","volume":"20","author":"X Guo","year":"2013","journal-title":"Clin Vaccine Immunol"},{"issue":"36","key":"pntd.0012411.ref022","first-page":"E7564","article-title":"Structures of phlebovirus glycoprotein Gn and identification of a neutralizing antibody epitope","volume":"114","author":"Y Wu","year":"2017","journal-title":"Proc Natl Acad Sci U S A"},{"key":"pntd.0012411.ref023","first-page":"e0186823","article-title":"Self-assembling Gn head ferritin nanoparticle vaccine provides full protection from lethal challenge of Dabie bandavirus in aged ferrets","volume":"2023","author":"D Kim","journal-title":"MBio"},{"issue":"3","key":"pntd.0012411.ref024","doi-asserted-by":"crossref","first-page":"e1011232","DOI":"10.1371\/journal.ppat.1011232","article-title":"Glucosylceramide is essential for Heartland and Dabie bandavirus glycoprotein-induced membrane fusion.","volume":"19","author":"T Xia","year":"2023","journal-title":"PLoS Pathog."},{"issue":"2","key":"pntd.0012411.ref025","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1002\/rmv.1776","article-title":"Systematic review of severe fever with thrombocytopenia syndrome: virology, epidemiology, and clinical characteristics.","volume":"24","author":"S Liu","year":"2014","journal-title":"Rev Med Virol."},{"key":"pntd.0012411.ref026","doi-asserted-by":"crossref","first-page":"839215","DOI":"10.3389\/fmed.2022.839215","article-title":"Effective Drugs Against Severe Fever With Thrombocytopenia Syndrome Virus in an in vitro Model.","volume":"9","author":"MS Bang","year":"2022","journal-title":"Front Med."},{"issue":"16","key":"pntd.0012411.ref027","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00743-17","article-title":"Mapping of Transcription Termination within the S Segment of SFTS Phlebovirus Facilitated Generation of NSs Deletant Viruses","volume":"91","author":"B Brennan","year":"2017","journal-title":"J Virol"},{"issue":"9","key":"pntd.0012411.ref028","doi-asserted-by":"crossref","DOI":"10.3390\/cells8090963","article-title":"Signaling Pathways of Type I and Type III Interferons and Targeted Therapies in Systemic Lupus Erythematosus.","volume":"8","author":"IT Chyuan","year":"2019","journal-title":"Cells"},{"key":"pntd.0012411.ref029","doi-asserted-by":"crossref","first-page":"1348836","DOI":"10.3389\/fimmu.2024.1348836","article-title":"Antiviral immunity of severe fever with thrombocytopenia syndrome: current understanding and implications for clinical treatment","volume":"15","author":"Y Niu","year":"2024","journal-title":"Front Immunol"},{"issue":"8","key":"pntd.0012411.ref030","doi-asserted-by":"crossref","first-page":"110039","DOI":"10.1016\/j.celrep.2021.110039","article-title":"Single-cell landscape of peripheral immune responses to fatal SFTS","volume":"37","author":"H Li","year":"2021","journal-title":"Cell Rep"},{"issue":"10","key":"pntd.0012411.ref031","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1016\/j.vaccine.2015.01.051","article-title":"Characterization of immunological responses in patients with severe fever with thrombocytopenia syndrome: a cohort study in China","volume":"33","author":"QB Lu","year":"2015","journal-title":"Vaccine"},{"issue":"1","key":"pntd.0012411.ref032","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1038\/s41541-020-00257-5","article-title":"Baseline mapping of severe fever with thrombocytopenia syndrome virology, epidemiology and vaccine research and development.","volume":"5","author":"NE Bopp","year":"2020","journal-title":"NPJ Vaccines."},{"issue":"11","key":"pntd.0012411.ref033","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.3201\/eid2211.160414","article-title":"Neutralizing Antibodies to Severe Fever with Thrombocytopenia Syndrome Virus 4 Years after Hospitalization, China","volume":"22","author":"YT Huang","year":"2016","journal-title":"Emerg Infect Dis"},{"issue":"4","key":"pntd.0012411.ref034","doi-asserted-by":"crossref","first-page":"e0175592","DOI":"10.1371\/journal.pone.0175592","article-title":"Seroprevalence of severe fever with thrombocytopenia syndrome virus in China: A systematic review and meta-analysis.","volume":"12","author":"P Li","year":"2017","journal-title":"PLoS ONE."},{"key":"pntd.0012411.ref035","doi-asserted-by":"crossref","first-page":"104","DOI":"10.3389\/fmicb.2017.00104","article-title":"Animal Models of Emerging Tick-Borne Phleboviruses: Determining Target Cells in a Lethal Model of SFTSV Infection.","volume":"8","author":"K Matsuno","year":"2017","journal-title":"Front Microbiol."},{"issue":"2","key":"pntd.0012411.ref036","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1128\/JCM.01319-11","article-title":"Preparation and evaluation of recombinant severe fever with thrombocytopenia syndrome virus nucleocapsid protein for detection of total antibodies in human and animal sera by double-antigen sandwich enzyme-linked immunosorbent assay","volume":"50","author":"Y Jiao","year":"2012","journal-title":"J Clin Microbiol"},{"key":"pntd.0012411.ref037","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1186\/s12985-015-0350-0","article-title":"Application of recombinant severe fever with thrombocytopenia syndrome virus nucleocapsid protein for the detection of SFTSV-specific human IgG and IgM antibodies by indirect ELISA.","volume":"12","author":"F Yu","year":"2015","journal-title":"Virol J."},{"issue":"1","key":"pntd.0012411.ref038","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1186\/s12985-023-02173-1","article-title":"Antibody production and characterization of the nucleoprotein of sever fever with thrombocytopenia syndrome virus (SFTSV) for effective diagnosis of SFTSV.","volume":"20","author":"K Lee","year":"2023","journal-title":"Virol J."},{"issue":"6","key":"pntd.0012411.ref039","doi-asserted-by":"crossref","first-page":"e38291","DOI":"10.1371\/journal.pone.0038291","article-title":"Critical epitopes in the nucleocapsid protein of SFTS virus recognized by a panel of SFTS patients derived human monoclonal antibodies.","volume":"7","author":"L Yu","year":"2012","journal-title":"PLoS ONE."},{"issue":"7","key":"pntd.0012411.ref040","doi-asserted-by":"crossref","first-page":"e2309","DOI":"10.1371\/journal.pntd.0002309","article-title":"A single immunization with MVA expressing GnGc glycoproteins promotes epitope-specific CD8+-T cell activation and protects immune-competent mice against a lethal RVFV infection","volume":"7","author":"E L0.3585\/w","year":"2013","journal-title":"PLoS Negl Trop Dis"},{"issue":"3","key":"pntd.0012411.ref041","doi-asserted-by":"crossref","first-page":"e91679","DOI":"10.1371\/journal.pone.0091679","article-title":"Concurrent measurement of dynamic changes in viral load, serum enzymes, T cell subsets, and cytokines in patients with severe fever with thrombocytopenia syndrome.","volume":"9","author":"J Li","year":"2014","journal-title":"PLoS ONE."},{"key":"pntd.0012411.ref042","article-title":"Self-assembling Gn head ferritin nanoparticle vaccine provides full protection from lethal challenge of Dabie Bandavirus in aged ferrets","author":"D Kim","year":"2023","journal-title":"bioRxiv: the preprint server for biology"},{"issue":"2","key":"pntd.0012411.ref043","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1089\/vim.2014.0100","article-title":"Immunization with recombinant SFTSV\/NSs protein does not promote virus clearance in SFTSV-infected C57BL\/6J mice","volume":"28","author":"R Liu","year":"2015","journal-title":"Viral Immunol"},{"key":"pntd.0012411.ref044","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.virol.2015.03.032","article-title":"Live attenuated vaccines: Historical successes and current challenges","volume":"479\u2013480","author":"PD Minor","year":"2015","journal-title":"Virology"},{"issue":"52","key":"pntd.0012411.ref045","doi-asserted-by":"crossref","first-page":"26900","DOI":"10.1073\/pnas.1914704116","article-title":"Cross-genotype protection of live-attenuated vaccine candidate for severe fever with thrombocytopenia syndrome virus in a ferret model","volume":"116","author":"KM Yu","year":"2019","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"pntd.0012411.ref046","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/s41564-018-0329-x","article-title":"Severe fever with thrombocytopenia syndrome phlebovirus non-structural protein activates TPL2 signalling pathway for viral immunopathogenesis.","volume":"4","author":"Y Choi","year":"2019","journal-title":"Nat Microbiol."},{"key":"pntd.0012411.ref047","first-page":"1","article-title":"Vesicular stomatitis virus: structure and function of virion components","volume":"73","author":"SU Emerson","year":"1976","journal-title":"Curr Top Microbiol Immunol"},{"key":"pntd.0012411.ref048","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.5604\/17322693.1083016","article-title":"[Vesicular stomatitis virus (VSV) as a vaccine vector for immunization against viral infections].","volume":"67","author":"T Tomczyk","year":"2013","journal-title":"Postepy Hig Med Dosw (Online)."},{"issue":"3","key":"pntd.0012411.ref049","doi-asserted-by":"crossref","first-page":"312","DOI":"10.4269\/ajtmh.1988.39.312","article-title":"A human case of encephalitis associated with vesicular stomatitis virus (Indiana serotype) infection.","volume":"39","author":"E Quiroz","year":"1988","journal-title":"Am J Trop Med Hyg"},{"issue":"9","key":"pntd.0012411.ref050","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.1080\/21645515.2018.1473698","article-title":"The vesicular stomatitis virus-based Ebola virus vaccine: From concept to clinical trials","volume":"14","author":"E Suder","year":"2018","journal-title":"Hum Vaccin Immunother"},{"issue":"9","key":"pntd.0012411.ref051","doi-asserted-by":"crossref","first-page":"4897","DOI":"10.1128\/JVI.03276-13","article-title":"VSV-GP: a potent viral vaccine vector that boosts the immune response upon repeated applications","volume":"88","author":"R Tober","year":"2014","journal-title":"J Virol"},{"key":"pntd.0012411.ref052","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1038\/s41541-018-0096-y","article-title":"Single dose of a rVSV-based vaccine elicits complete protection against severe fever with thrombocytopenia syndrome virus","volume":"4","author":"F Dong","year":"2019","journal-title":"NPJ Vaccines"},{"issue":"3","key":"pntd.0012411.ref053","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.chom.2020.07.018","article-title":"Replication-Competent Vesicular Stomatitis Virus Vaccine Vector Protects against SARS-CoV-2-Mediated Pathogenesis in Mice.","volume":"28","author":"JB Case","year":"2020","journal-title":"Cell Host Microbe."},{"issue":"8","key":"pntd.0012411.ref054","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1586\/erv.11.79","article-title":"Vaccinia viruses: vaccines against smallpox and vectors against infectious diseases and tumors.","volume":"10","author":"SR Walsh","year":"2011","journal-title":"Expert Rev Vaccines"},{"issue":"50","key":"pntd.0012411.ref055","doi-asserted-by":"crossref","first-page":"6436","DOI":"10.1016\/j.vaccine.2016.06.059","article-title":"Vector-based genetically modified vaccines: Exploiting Jenner\u2019s legacy","volume":"34","author":"B Ramezanpour","year":"2016","journal-title":"Vaccine"},{"issue":"23","key":"pntd.0012411.ref056","doi-asserted-by":"crossref","first-page":"7415","DOI":"10.1073\/pnas.79.23.7415","article-title":"Vaccinia virus: a selectable eukaryotic cloning and expression vector","volume":"79","author":"M Mackett","year":"1982","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"16","key":"pntd.0012411.ref057","doi-asserted-by":"crossref","first-page":"4927","DOI":"10.1073\/pnas.79.16.4927","article-title":"Construction of poxviruses as cloning vectors: insertion of the thymidine kinase gene from herpes simplex virus into the DNA of infectious vaccinia virus","volume":"79","author":"D Panicali","year":"1982","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"12","key":"pntd.0012411.ref058","article-title":"Generation of Multiple Arbovirus-like Particles Using a Rapid Recombinant Vaccinia Virus Expression Platform.","volume":"11","author":"Y Wang","year":"2022","journal-title":"Pathogens (Basel, Switzerland)."},{"issue":"6979","key":"pntd.0012411.ref059","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1038\/nature02331","article-title":"Immunogenicity of a highly attenuated MVA smallpox vaccine and protection against monkeypox","volume":"428","author":"PL Earl","year":"2004","journal-title":"Nature"},{"key":"pntd.0012411.ref060","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/bs.aivir.2016.07.001","article-title":"Modified Vaccinia Virus Ankara: History, Value in Basic Research, and Current Perspectives for Vaccine Development","volume":"97","author":"A Volz","year":"2017","journal-title":"Adv Virus Res"},{"issue":"9","key":"pntd.0012411.ref061","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1093\/infdis\/jir527","article-title":"Safety and immunogenicity of LC16m8, an attenuated smallpox vaccine in vaccinia-naive adults","volume":"204","author":"JS Kennedy","year":"2011","journal-title":"J Infect Dis"},{"issue":"10","key":"pntd.0012411.ref062","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1001\/jama.2009.289","article-title":"Clinical and immunological response to attenuated tissue-cultured smallpox vaccine LC16m8","volume":"301","author":"T Saito","year":"2009","journal-title":"JAMA"},{"issue":"2","key":"pntd.0012411.ref063","doi-asserted-by":"crossref","first-page":"e1008859","DOI":"10.1371\/journal.ppat.1008859","article-title":"A highly attenuated vaccinia virus strain LC16m8-based vaccine for severe fever with thrombocytopenia syndrome","volume":"17","author":"T Yoshikawa","year":"2021","journal-title":"PLoS Pathog"},{"issue":"1","key":"pntd.0012411.ref064","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1080\/02648725.2018.1471643","article-title":"Vaccinia-based vaccines to biothreat and emerging viruses.","volume":"34","author":"LP Nagata","year":"2018","journal-title":"Biotechnol Genet Eng Rev"},{"issue":"49","key":"pntd.0012411.ref065","doi-asserted-by":"crossref","first-page":"7022","DOI":"10.1016\/j.vaccine.2022.10.047","article-title":"Advances in vaccinia virus-based vaccine vectors, with applications in flavivirus vaccine development","volume":"40","author":"L Xie","year":"2022","journal-title":"Vaccine"},{"issue":"6","key":"pntd.0012411.ref066","doi-asserted-by":"crossref","first-page":"297","DOI":"10.2144\/btn-2022-0051","article-title":"Adenovirus vector system: construction, history and therapeutic applications","volume":"73","author":"A Syyam","year":"2022","journal-title":"Biotechniques"},{"issue":"2","key":"pntd.0012411.ref067","doi-asserted-by":"crossref","first-page":"e25","DOI":"10.1371\/journal.ppat.0030025","article-title":"Mechanism of ad5 vaccine immunity and toxicity: fiber shaft targeting of dendritic cells","volume":"3","author":"C Cheng","year":"2007","journal-title":"PLoS Pathog"},{"issue":"10240","key":"pntd.0012411.ref068","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1016\/S0140-6736(20)31208-3","article-title":"Safety, tolerability, and immunogenicity of a recombinant adenovirus type-5 vectored COVID-19 vaccine: a dose-escalation, open-label, non-randomised, first-in-human trial","volume":"395","author":"FC Zhu","year":"2020","journal-title":"Lancet (London, England)."},{"issue":"3","key":"pntd.0012411.ref069","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1093\/infdis\/jiy187","article-title":"Immunization With a Novel Human Type 5 Adenovirus-Vectored Vaccine Expressing the Premembrane and Envelope Proteins of Zika Virus Provides Consistent and Sterilizing Protection in Multiple Immunocompetent and Immunocompromised Animal Models","volume":"218","author":"Q Guo","year":"2018","journal-title":"J Infect Dis"},{"issue":"43","key":"pntd.0012411.ref070","doi-asserted-by":"crossref","first-page":"6011","DOI":"10.1016\/j.vaccine.2009.07.073","article-title":"An adenovirus type 5 (AdV5) vector encoding an envelope domain III-based tetravalent antigen elicits immune responses against all four dengue viruses in the presence of prior AdV5 immunity.","volume":"27","author":"S Khanam","year":"2009","journal-title":"Vaccine"},{"issue":"10069","key":"pntd.0012411.ref071","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/S0140-6736(16)32617-4","article-title":"Safety and immunogenicity of a recombinant adenovirus type-5 vector-based Ebola vaccine in healthy adults in Sierra Leone: a single-centre, randomised, double-blind, placebo-controlled, phase 2 trial","volume":"389","author":"FC Zhu","year":"2017","journal-title":"Lancet (London, England)."},{"key":"pntd.0012411.ref072","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.3389\/fmicb.2020.01473","article-title":"Recombinant Human Adenovirus Type 5 Co-expressing RABV G and SFTSV Gn Induces Protective Immunity Against Rabies Virus and Severe Fever With Thrombocytopenia Syndrome Virus in Mice.","volume":"11","author":"Z Zhao","year":"2020","journal-title":"Front Microbiol"},{"issue":"24","key":"pntd.0012411.ref073","doi-asserted-by":"crossref","first-page":"3468","DOI":"10.1016\/j.vaccine.2018.04.082","article-title":"Heterologous prime-boost vaccination with adenoviral vector and protein nanoparticles induces both Th1 and Th2 responses against Middle East respiratory syndrome coronavirus","volume":"36","author":"SY Jung","year":"2018","journal-title":"Vaccine"},{"issue":"12","key":"pntd.0012411.ref074","doi-asserted-by":"crossref","first-page":"e50447","DOI":"10.1371\/journal.pone.0050447","article-title":"Optimising immunogenicity with viral vectors: mixing MVA and HAdV-5 expressing the mycobacterial antigen Ag85A in a single injection.","volume":"7","author":"G Betts","year":"2012","journal-title":"PLoS ONE."},{"issue":"6","key":"pntd.0012411.ref075","doi-asserted-by":"crossref","first-page":"e67123","DOI":"10.1371\/journal.pone.0067123","article-title":"Comparison of Heterologous Prime-Boost Strategies against Human Immunodeficiency Virus Type 1 Gag Using Negative Stranded RNA Viruses","volume":"8","author":"TM Lawrence","year":"2013","journal-title":"PLoS ONE"},{"issue":"2","key":"pntd.0012411.ref076","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1128\/IAI.01410-13","article-title":"Immunogenicity of a prime-boost vaccine containing the circumsporozoite proteins of Plasmodium vivax in rodents","volume":"82","author":"LH Teixeira","year":"2014","journal-title":"Infect Immun"},{"issue":"6","key":"pntd.0012411.ref077","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1038\/s41571-022-00610-8","article-title":"COVID-19 vaccines in patients with cancer: immunogenicity, efficacy and safety.","volume":"19","author":"A Fendler","year":"2022","journal-title":"Nat Rev Clin Oncol."},{"issue":"1","key":"pntd.0012411.ref078","doi-asserted-by":"crossref","first-page":"8189","DOI":"10.1038\/s41598-023-35328-9","article-title":"Heterologous vaccination utilizing viral vector and protein platforms confers complete protection against SFTSV.","volume":"13","author":"JY Kim","year":"2023","journal-title":"Sci Rep."},{"key":"pntd.0012411.ref079","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s12979-019-0164-9","article-title":"Immunosenescence and human vaccine immune responses","volume":"16","author":"SN Crooke","year":"2019","journal-title":"Immun Ageing"},{"key":"pntd.0012411.ref080","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S0065-2660(05)54011-2","article-title":"DNA vaccine.","volume":"54","author":"Z. Cui","year":"2005","journal-title":"Adv Genet"},{"key":"pntd.0012411.ref081","first-page":"3","article-title":"DNA vaccine design","volume":"127","author":"JL Brandsma","year":"2006","journal-title":"Methods Mol Med"},{"key":"pntd.0012411.ref082","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.actbio.2018.08.033","article-title":"Engineering DNA vaccines against infectious diseases","volume":"80","author":"J Lee","year":"2018","journal-title":"Acta Biomater"},{"issue":"9","key":"pntd.0012411.ref083","doi-asserted-by":"crossref","first-page":"4081","DOI":"10.7150\/thno.70853","article-title":"Advances in the polymeric delivery of nucleic acid vaccines.","volume":"12","author":"G Chen","year":"2022","journal-title":"Theranostics"},{"issue":"1","key":"pntd.0012411.ref084","doi-asserted-by":"crossref","first-page":"3836","DOI":"10.1038\/s41467-019-11815-4","article-title":"Development of a SFTSV DNA vaccine that confers complete protection against lethal infection in ferrets","volume":"10","author":"JE Kwak","year":"2019","journal-title":"Nat Commun"},{"issue":"3","key":"pntd.0012411.ref085","doi-asserted-by":"crossref","first-page":"e0007813","DOI":"10.1371\/journal.pntd.0007813","article-title":"Vaccination with single plasmid DNA encoding IL-12 and antigens of severe fever with thrombocytopenia syndrome virus elicits complete protection in IFNAR knockout mice.","volume":"14","author":"JG Kang","year":"2020","journal-title":"PLoS Negl Trop Dis."},{"issue":"5","key":"pntd.0012411.ref086","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1016\/j.ymthe.2022.02.016","article-title":"COVID-19 mRNA vaccines: Platforms and current developments.","volume":"30","author":"GT Szab","year":"2022","journal-title":"Mol Ther"},{"issue":"6","key":"pntd.0012411.ref087","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1177\/08971900211009650","article-title":"Review of COVID-19 mRNA Vaccines: BNT162b2 and mRNA-1273.","volume":"35","author":"SP Teo","year":"2022","journal-title":"J Pharm Pract."},{"issue":"4","key":"pntd.0012411.ref088","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.ymthe.2019.01.020","article-title":"mRNA as a Transformative Technology for Vaccine Development to Control Infectious Diseases","volume":"27","author":"G Maruggi","year":"2019","journal-title":"Mol Ther"},{"key":"pntd.0012411.ref089","doi-asserted-by":"crossref","first-page":"594","DOI":"10.3389\/fimmu.2019.00594","article-title":"Advances in mRNA Vaccines for Infectious Diseases.","volume":"10","author":"C Zhang","year":"2019","journal-title":"Front Immunol."},{"issue":"11","key":"pntd.0012411.ref090","doi-asserted-by":"crossref","first-page":"e29203","DOI":"10.1002\/jmv.29203","article-title":"SFTSV Gn-Head mRNA vaccine confers efficient protection against lethal viral challenge","volume":"95","author":"D Kim","year":"2023","journal-title":"J Med Virol"},{"key":"pntd.0012411.ref091","first-page":"e0076924","article-title":"A full-length glycoprotein mRNA vaccine confers complete protection against severe fever with thrombocytopenia syndrome virus, with broad-spectrum protective effects against bandaviruses","volume":"2024","author":"J Lu","journal-title":"J Virol"},{"key":"pntd.0012411.ref092","doi-asserted-by":"crossref","first-page":"797189","DOI":"10.3389\/fmicb.2021.797189","article-title":"Animal Model of Severe Fever With Thrombocytopenia Syndrome Virus Infection.","volume":"12","author":"J Sun","year":"2021","journal-title":"Front Microbiol."},{"issue":"4","key":"pntd.0012411.ref093","doi-asserted-by":"crossref","DOI":"10.3390\/v13040627","article-title":"Vaccine Development for Severe Fever with Thrombocytopenia Syndrome","volume":"13","author":"T. Yoshikawa","year":"2021","journal-title":"Viruses"},{"issue":"11","key":"pntd.0012411.ref094","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19113605","article-title":"DNA Vaccines-How Far From Clinical Use?","volume":"19","author":"D Hobernik","year":"2018","journal-title":"Int J Mol Sci."},{"issue":"3","key":"pntd.0012411.ref095","doi-asserted-by":"crossref","first-page":"468","DOI":"10.4269\/ajtmh.15-0047","article-title":"Phylogenetic Analysis of Severe Fever with Thrombocytopenia Syndrome Virus in South Korea and Migratory Bird Routes Between China, South Korea, and Japan","volume":"93","author":"Y Yun","year":"2015","journal-title":"Am J Trop Med Hyg"}],"container-title":["PLOS Neglected Tropical Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0012411","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,29]],"date-time":"2024-08-29T17:28:47Z","timestamp":1724952527000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0012411"}},"subtitle":[],"editor":[{"given":"Gregory","family":"Gromowski","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2024,8,29]]},"references-count":95,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2024,8,29]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pntd.0012411","relation":{},"ISSN":["1935-2735"],"issn-type":[{"value":"1935-2735","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,29]]}}}